Reference

  1. Centers for Disease Control and Prevention (CDC). Most recent national asthma data. Last updated March 24, 2020. Accessed June 12, 2020.
  2. Allard B, Aspeslagh S, Garaud S, et al. Immuno-oncology-101: overview of major concepts and translational perspectives. Semin Cancer Biol. 2018;52(pt 2):1-11. doi:10.1016/j.semcancer.2018.02.005.
  3. Medicines in development for immuno-oncology 2017 report. PhRMA. June 1, 2017. Accessed January 30, 2019. Reference Link
  4. Medicines in development for immuno-oncology 2017 report. PhRMA. June 1, 2017. Accessed January 30, 2019. https://solidarites-sante.gouv.fr/prevention-en-sante/preserver-sa-sante/vaccination/calendrier-vaccinal

Asthma Forward is a registered trade mark of the GSK group of companies.
©XXXX GSK group of companies. All rights reserved.

SE-GBL-FVU-WCNT-XXXXXX
Date of preparation: XXXXX

Reference

  1. Centers for Disease Control and Prevention (CDC). Most recent national asthma data. Last updated March 24, 2020. Accessed June 12, 2020.
  2. Allard B, Aspeslagh S, Garaud S, et al. Immuno-oncology-101: overview of major concepts and translational perspectives. Semin Cancer Biol. 2018;52(pt 2):1-11. doi:10.1016/j.semcancer.2018.02.005.
  3. Medicines in development for immuno-oncology 2017 report. PhRMA. June 1, 2017. Accessed January 30, 2019. Reference Link

Asthma Forward is a registered trade mark of the GSK group of companies.
©XXXX GSK group of companies. All rights reserved.

SE-GBL-FVU-WCNT-XXXXXX
Date of preparation: XXXXX